These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8590160

  • 1. Variability in serum pepsinogen levels in an asymptomatic population.
    Knight T, Greaves S, Wilson A, Hengels K, Newell D, Corlett M, Webb P, Forman D, Elder J.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):647-54. PubMed ID: 8590160
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [Abstract] [Full Text] [Related]

  • 3. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 4. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Sep; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 5. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 6. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Jul; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of Helicobacter pylori and gastritis in southern Germany. Results of a representative cross-sectional study].
    Haubrich T, Boeing H, Göres W, Hengels KJ, Scheuermann W, Wahrendorf J.
    Z Gastroenterol; 1993 Jul; 31(7-8):432-6. PubMed ID: 8379230
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]

  • 10. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 11. Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y, Shinomura Y, Kanayama S, Miyazaki Y, Bonilla Palacios JJ, Matsuzawa Y.
    Ital J Gastroenterol; 1996 Feb; 28(8):457-61. PubMed ID: 9032589
    [Abstract] [Full Text] [Related]

  • 12. Role of Helicobacter pylori in chronic gastritis: a prospective study.
    Kudo M, Asaka M, Kato M, Katagiri M, Kagaya H, Nishikawa K, Koshiyama T, Hokari K, Meguro T, Takeda H.
    J Clin Gastroenterol; 1995 Feb; 21 Suppl 1():S174-8. PubMed ID: 8775014
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 14. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G.
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [Abstract] [Full Text] [Related]

  • 15. Serum pepsinogen I in childhood Helicobacter pylori gastritis: its relation to mucosal peptic activity.
    Yahav J, Oderda G, Diver-Haber A, Fradkin A, Keller N, Altare F, Ansaldi N, Jonas A.
    Isr J Med Sci; 1996 Jan; 32(1):56-9. PubMed ID: 8550350
    [Abstract] [Full Text] [Related]

  • 16. Using serum pepsinogens wisely in a clinical practice.
    Miki K, Urita Y.
    J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
    [Abstract] [Full Text] [Related]

  • 17. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K.
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [Abstract] [Full Text] [Related]

  • 18. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.
    Bodger K, Wyatt JI, Heatley RV.
    Helicobacter; 2001 Sep; 6(3):216-24. PubMed ID: 11683924
    [Abstract] [Full Text] [Related]

  • 19. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.
    Scand J Clin Lab Invest; 2005 Sep; 65(4):291-9. PubMed ID: 16076684
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
    Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J.
    Br J Cancer; 1996 Mar; 73(6):819-24. PubMed ID: 8611388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.